Skip to content
Open access

Comparative Value of Cognitive and Functional Assessments for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s Disease: An ADNI Cohort Study

Sep 2026 · medRxiv · 0 citations · 20 references
Medicine

TL;DR

Episodic memory demonstrated the strongest predictive performance among the individual assessment domains evaluated of 24-month progression from MCI to AD, with functional assessment providing substantial complementary value.

Abstract

Accurate prediction of progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is important for prognosis, patient management, and clinical trial enrollment. Cognitive and functional assessments are routinely used in memory clinics, but their relative predictive value remains unclear. We sought to identify which assessments are most predictive of 24-month progression from MCI to AD. We analyzed 2,430 participants with baseline MCI from the Alzheimer's Disease Neuroimaging Initiative (ADNI) who were classified by 24-month progression to AD. Extreme Gradient Boosting (XGBoost) models were trained using repeated stratified 5-fold cross-validation with 10 repetitions. We compared demographic and genetic variables, global cognitive measures (MMSE, ADAS-Cog13, CDR-SB, MoCA), episodic memory, executive function, functional status, and Everyday Cognition (ECog) questionnaires. The baseline clinical model (age, sex, education, APOE {varepsilon}4 status) achieved an area under the receiver operating characteristic curve (AUC) of 0.692. Episodic memory showed the highest predictive performance (AUC = 0.915), followed by the Functional Activities Questionnaire (AUC = 0.913). Combining episodic memory, functional assessment, and executive function achieved the best performance (AUC = 0.943, sensitivity = 0.857, specificity = 0.889). Among individual memory measures, Logical Memory Delayed Recall achieved the highest standalone performance (AUC = 0.896), whereas RAVLT Learning provided minimal incremental value. Episodic memory demonstrated the strongest predictive performance among the individual assessment domains evaluated of 24-month progression from MCI to AD, with functional assessment providing substantial complementary value. Streamlined assessment batteries emphasizing episodic memory and functional status may improve efficient risk stratification in memory clinics and AD clinical trials.

Read PDF

Similar papers

Open access Aug 2026

Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia

Although polygenic burden contributes to variability in cognitive trajectories, its added predictive value beyond routinely available clinical variables remains modest.

B. Calm, Adrián Hinojosa-Calleja, F. García-Gutiérrez et al. · 0 citations
Sep 2026

Utility of biomarkers in prediction of future cognition in Alzheimer's disease continuum changes over time

Background While multiple biomarkers of Alzheimer's disease (AD) and mild cognitive impairment (MCI) predict cognitive decline over time, their predictive value at each of the disease stages remains unclear. Objective To examine how the predictive power of biomarkers changes over time. Methods We dynamically ranked a c...

E. Ramezannezhad, Mohammad Dehghani · 0 citations
Open access Sep 2026

Modelling the risk of conversion from mild cognitive impairment to Alzheimer’s disease using machine learning

Mild cognitive impairment (MCI) is a transitional state between normal aging and dementia, characterized by subtle cognitive decline. While not all individuals with MCI will progress to Alzheimer’s disease (AD), early identification of those at high risk is crucial for timely interventions. Machine learning algorit...

A. Mouiha, Mohamed Taiebine, Jaouad El-Hilaly · 0 citations
Sep 2026

Recognition memory as a neuropsychological marker of progression in early-stage Alzheimer's disease: a 24-month prospective cohort study.

SDT-derived recognition indices, especially d'prime, provide clinically relevant prognostic information in a-MCI and adding d' to delayed recall and biomarkers may improve risk stratification, follow-up planning, and selection for disease-modifying trials.

María Julieta Russo, José Bueri, L. Alba-Ferrara et al. · 0 citations
Sep 2026

Multimodal prediction of MCI-to-dementia conversion over a two-year window.

An explainable multimodal machine-learning framework to predict progression from MCI to dementia within a clinically meaningful two-year period is developed and the convergence of cognitive impairment and region-specific neurodegeneration emerged as the strongest indicator of conversion risk.

Bipul Simkhada, T. Y. Liang, Xue-Ting Cui et al. · 2 citations · ⚡1
Sep 2026

Comparison of baseline characteristics between cognitively normal and mild cognitive impairment and association of white matter hyperintensity trajectories with diagnostic outcomes, cognition, and amyloid-β protein: A longitudinal study

WMH baseline and trajectory changes are key risk factors for CN cognitive decline and WMH trajectory changes are linked to cognitive function and brain Aβ deposition.

W. Ba, Cui-Ping Bao, Ying-Xun Gong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.